Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Cooper

Showing results (61-70 of 399) with videos related to

Pageof 40
Sort By:
Current Opinion in Nephrology and Hypertension|April 20, 2004
New insights into the significance of microalbuminuriaRichard J MacIsaac, George Jerums, Mark E Cooper
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 8, 2006
Preventing diabetes in patients with hypertension: one more reason to block the renin-angiotensin systemMark E Cooper, Chris Tikellis, Merlin C Thomas
Current Diabetes Reports|December 1, 2005
Lipids and diabetic renal diseaseMark E Cooper, Karin A M Jandeleit-Dahm
International Journal of Molecular Sciences|March 27, 2020
Glucose and Blood Pressure-Dependent Pathways-The Progression of Diabetic Kidney DiseaseDevang M Patel, Madhura Bose, Mark E Cooper
Diabetes Care|March 11, 2006
Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetesPeter Rossing, Mark E Cooper, Hans-Henrik Parving
Expert Opinion on Pharmacotherapy|May 6, 2022
Recent advances in the pharmacotherapeutic management of diabetic kidney diseaseTomasz J Block, Duygu Batu, Mark E Cooper
Nature Reviews. Nephrology|November 11, 2015
Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney diseaseMerlin C Thomas, Mark E Cooper, Paul Zimmet
Current Hypertension Reports|September 3, 2004
Antiproteinuric effect of RAS blockade: new mechanismsMarkus Lassila, Mark E Cooper, Karin Jandeleit-Dahm
Expert Opinion on Emerging Drugs|September 4, 2008
Agents in development for the treatment of diabetic nephropathySu-Yen Goh, Mariusz Jasik, Mark E Cooper
Expert Opinion on Investigational Drugs|September 13, 2002
Advanced glycation end products and diabetic complicationsAlan W Stitt, Alicia J Jenkins, Mark E Cooper
Pageof 40

Showing results (61-70 of 399) with videos related to

Sort By:
Pageof 40
Current Opinion in Nephrology and Hypertension|April 20, 2004
New insights into the significance of microalbuminuriaRichard J MacIsaac, George Jerums, Mark E Cooper
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 8, 2006
Preventing diabetes in patients with hypertension: one more reason to block the renin-angiotensin systemMark E Cooper, Chris Tikellis, Merlin C Thomas
Current Diabetes Reports|December 1, 2005
Lipids and diabetic renal diseaseMark E Cooper, Karin A M Jandeleit-Dahm
International Journal of Molecular Sciences|March 27, 2020
Glucose and Blood Pressure-Dependent Pathways-The Progression of Diabetic Kidney DiseaseDevang M Patel, Madhura Bose, Mark E Cooper
Diabetes Care|March 11, 2006
Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetesPeter Rossing, Mark E Cooper, Hans-Henrik Parving
Expert Opinion on Pharmacotherapy|May 6, 2022
Recent advances in the pharmacotherapeutic management of diabetic kidney diseaseTomasz J Block, Duygu Batu, Mark E Cooper
Nature Reviews. Nephrology|November 11, 2015
Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney diseaseMerlin C Thomas, Mark E Cooper, Paul Zimmet
Current Hypertension Reports|September 3, 2004
Antiproteinuric effect of RAS blockade: new mechanismsMarkus Lassila, Mark E Cooper, Karin Jandeleit-Dahm
Expert Opinion on Emerging Drugs|September 4, 2008
Agents in development for the treatment of diabetic nephropathySu-Yen Goh, Mariusz Jasik, Mark E Cooper
Expert Opinion on Investigational Drugs|September 13, 2002
Advanced glycation end products and diabetic complicationsAlan W Stitt, Alicia J Jenkins, Mark E Cooper
Pageof 40